Alessandro Rambaldi to Europe
This is a "connection" page, showing publications Alessandro Rambaldi has written about Europe.
Connection Strength
0.136
-
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia. 2021 02; 35(2):485-493.
Score: 0.066
-
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. Blood Cancer J. 2021 02 04; 11(2):21.
Score: 0.016
-
Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia. Hematology. 2019 Dec; 24(1):337-348.
Score: 0.015
-
Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT. Eur J Cancer. 2019 01; 106:212-219.
Score: 0.014
-
Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study. Bone Marrow Transplant. 2018 03; 53(3):291-299.
Score: 0.013
-
Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population. Leuk Lymphoma. 2016 May; 57(5):1234-7.
Score: 0.012